CASE STUDY: BEHAVIOR CHANGE
The Challenge
Despite clinical acceptance of the efficacy of long-acting injectables (LAIs) to provide prolonged stability for people suffering from schizophrenia, they still only make up about 13% of the market. Psychiatrists continue to prescribe daily orals, often citing patient acceptance as a major barrier. This fuels a cycle of oral nonadherence that often leads to relapse and loss.
We needed to remind HCPs about the devastating consequences of relapse and help them overcome challenges with patient acceptance, with the goal of motivating earlier and broader use of LAIs.
The Solution
We launched Disrupt the Decline, a compelling unbranded video series paired with resources to enable more productive LAI conversations.
At DiD, we prioritize customer-centric marketing and strive to always include the clinician’s point of view in our approach to market research, strategic insight development, and creative execution.
Outcomes
- +500% increase in exposures and digital content engagement
- 2X increase in time on site
- 62% of site visitors watches at least one full video
